Adherence, Medication: Clinical Trials

3 trials for Adherence, Medication, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 active not recruiting. 3 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 33Completed 2, Active not recruiting 1

Follow Adherence, Medication: new trials by email Literature Review of Adherence, Medication trials Research Report on Adherence, Medication

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Testing a Real-time Electronic Antiretroviral Adherence Monitoring Intervention
A-TEAM - HIV Infections, Adherence, Medication
Phase 3Active not recruitingUniversity of Illinois at Chicago1262024-10-012026-08-17
Next Generation Ingestible Sensors for Medication Adherence Measurement
Next-generation Reader and ID-Cap System, Truvada for pre-exposure prophylaxis (PrEP), Biktarvy for antiretroviral therapy (ART) - HIV Infection, Adherence, Medication
Phase 3CompletedBrigham and Women's Hospital152023-02-062024-09-25
SmartSteps: A Context-Aware, PrEP Adherence Intervention for Individuals With Substance Use Disorder
Descovy or Truvada, ID-Cap System, Beiwe - HIV Infections, Substance Use
Phase 3CompletedBrigham and Women's Hospital402022-12-202026-07-21

Narrower conditions

HIV Infections (3)  ·  Medication Adherence (3)  ·  Treatment Adherence and Compliance (2)  ·  Substance-Related Disorders (1)

Broader conditions

Behavior (3)  ·  Blood-Borne Infections (3)  ·  Communicable Diseases (3)  ·  Genital Diseases (3)  ·  Health Behavior (3)  ·  Immune System Diseases (3)  ·  Immunologic Deficiency Syndromes (3)  ·  Infections (3)  ·  Lentivirus Infections (3)  ·  Patient Acceptance of Health Care (3)  ·  Patient Compliance (3)  ·  RNA Virus Infections (3)  ·  Retroviridae Infections (3)  ·  Sexually Transmitted Diseases (3)  ·  Sexually Transmitted Diseases, Viral (3)

Interventions

Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination (2)  ·  Drug Delivery Systems (1)  ·  Pre-Exposure Prophylaxis (1)  ·  bictegravir, emtricitabine, tenofovir alafenamide, drug combination (1)  ·  emtricitabine tenofovir alafenamide (1)

Sponsors

Brigham and Women's Hospital (2)  ·  University of Illinois at Chicago (1)

Countries

United States (3)

Top investigators

Mark Dworkin, MD (1)  ·  Peter Chai, MD, MMS (1)  ·  Peter R Chai, MD MMS (1)

NIH funding

DP2DA056107 (1)